Cargando…
Repression of transcription factor AP-2 alpha by PPARγ reveals a novel transcriptional circuit in basal-squamous bladder cancer
The discovery of bladder cancer transcriptional subtypes provides an opportunity to identify high risk patients, and tailor disease management. Recent studies suggest tumor heterogeneity contributes to regional differences in molecular subtype within the tumor, as well as during progression and foll...
Autores principales: | Yamashita, Hironobu, Kawasawa, Yuka I., Shuman, Lauren, Zheng, Zongyu, Tran, Truc, Walter, Vonn, Warrick, Joshua I., Chen, Guoli, Al-Ahmadie, Hikmat, Kaag, Matthew, Wong, Pak Kin, Raman, Jay D., DeGraff, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879593/ https://www.ncbi.nlm.nih.gov/pubmed/31772149 http://dx.doi.org/10.1038/s41389-019-0178-3 |
Ejemplares similares
-
FOXA1, GATA3 and PPARɣ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines
por: Warrick, Joshua I., et al.
Publicado: (2016) -
Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes
por: Li, Huili, et al.
Publicado: (2020) -
Characterization of Histone Deacetylase Expression Within In Vitro and In Vivo Bladder Cancer Model Systems
por: Buckwalter, Jenna M., et al.
Publicado: (2019) -
A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma
por: Warrick, Joshua I., et al.
Publicado: (2022) -
Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS
por: Yee, Christopher H., et al.
Publicado: (2019)